| Followers | 19 |
| Posts | 6542 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Thursday, May 12, 2022 10:05:11 AM
Take advantage of the MIndMed Games Dilemma YQU Understand. Cost average down but be Patient and be Prudent YQU Understand. Have Mercy WQLF Ahooooooo
Recent DFTX News
- New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States • Business Wire • 03/31/2026 11:00:00 AM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 03/30/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 10:43:44 PM
- Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026 • Business Wire • 03/26/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2026 09:41:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2026 09:40:41 PM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 03/09/2026 08:01:00 PM
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions • PR Newswire (US) • 03/09/2026 02:50:00 PM
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions • PR Newswire (Canada) • 03/09/2026 02:50:00 PM
- Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments • PR Newswire (Canada) • 02/27/2026 04:44:00 PM
- Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments • PR Newswire (US) • 02/27/2026 04:44:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:10:27 PM
- Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates • Business Wire • 02/26/2026 09:01:00 PM
- Definium Therapeutics to Participate at Upcoming Investor Conferences • Business Wire • 02/24/2026 12:01:00 PM
- Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 • Business Wire • 02/19/2026 09:01:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:21:24 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/13/2026 01:42:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 09:54:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 09:53:18 PM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 02/02/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2026 12:30:27 PM
- Definium Therapeutics Appoints Roger Adsett to Board of Directors • Business Wire • 01/29/2026 12:00:00 PM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 01/26/2026 09:01:00 PM
- Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care • Business Wire • 01/20/2026 12:00:00 PM
- 2026 Asset Growth: Why Federal Compliance Is the New Metric • GlobeNewswire Inc. • 01/19/2026 05:20:49 PM
